サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1702289

人工透析の市場規模、シェア、動向、予測：タイプ、製品・サービス、エンドユーザー、地域別、2025年～2033年

Dialysis Market Size, Share, Trends and Forecast by Type, Product and Services, End User, and Region, 2025-2033

出版日
発行
IMARC
ページ情報
英文 141 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
人工透析の市場規模、シェア、動向、予測：タイプ、製品・サービス、エンドユーザー、地域別、2025年～2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工透析の世界市場規模は、2024年に1,208億5,000万米ドルとなりました。今後、IMARC Groupは、市場は2033年までに1,804億2,000万米ドルに達し、2025～2033年のCAGRは4.09%になると予測しています。2024年の市場シェアは現在北米が41.0％を占め、市場を独占しています。市場促進要因としては、慢性腎臓病や末期腎臓病の増加、糖尿病や高血圧患者の増加、透析機器の技術進歩、医療費の増加、在宅透析ソリューションの拡大、有利な政府政策、償還イニシアティブ、世界人口の高齢化などが挙げられます。

透析は、腎臓が自然に機能しなくなった人のための重要な腎代替療法です。この医療処置は、患者の血流から毒素、余分な水分、塩分、溶質を除去し、より健康的なバランスを効果的に回復させるという重要な役割を担っています。透析の主な目的は、血液を浄化し、体内の適切な電解質レベルを回復することです。この治療には、主に血液透析と腹膜透析の2種類があります。血液透析では、体外で血液を浄化します。この方法は血液中の不純物を効果的に取り除き、患者さんが安定した状態を取り戻すのに役立ちます。一方、腹膜透析は腹膜という腹部の内膜を利用して血液を浄化します。腹膜を透析媒体として利用することで、血液浄化に体内からアプローチする方法です。血液透析も腹膜透析も、腎臓に関連するさまざまな疾患の治療に役立っています。これらの治療は、急性腎障害への対応、慢性腎疾患の管理、腎移植のサポート、あるいは移植が実行不可能な場合の恒久的な解決策として一般的に行われています。透析は、腎機能障害と闘う人々の生活の質を著しく向上させるため、その重要性はいくら強調してもしすぎることはありません。慎重な実施と医療技術の継続的な進歩により、透析は腎臓のサポートが必要な患者の生命線としての役割を果たし続けています。

世界市場の主な原動力は、慢性腎臓病の有病率の増加です。これに伴い、腎臓関連の問題を抱えやすい高齢化人口の増加が市場に大きく寄与しています。さらに、腎臓の健康や利用可能な治療オプションに対する意識の高まりが、市場にプラスの影響を与えています。これとは別に、より効率的な透析手技につながる急速な技術進歩が、市場に多くの機会をもたらしています。さらに、革新的な透析技術の研究開発への多額の投資が市場を活性化しています。さらに、腎臓病の主な原因である糖尿病の罹患率の増加が、透析の需要を促進しています。さらに、新興国市場におけるヘルスケアインフラの拡充も市場を後押ししています。在宅透析ソリューションに対する需要の高まりが市場を強化しています。

人工透析の市場動向/促進要因：

ライフスタイルの変化による腎臓合併症の増加

ライフスタイルの変化が市場を刺激しています。食生活の乱れ、座りっぱなしの日常生活、高いストレスレベルを特徴とする現代のライフスタイルは、腎臓合併症の増加に寄与しています。加工食品の多い不健康な食事、塩分の多い食事、水分補給不足は、腎臓病の主な原因である高血圧や糖尿病などの慢性疾患につながる可能性があります。生活習慣要因と腎臓合併症の相関関係は、慢性腎臓病の有病率の上昇を促しています。このような腎臓に関連する問題の増加により、透析治療に対する需要が増加しています。患者数の拡大により透析サービスの拡大が必要となり、人工透析の市場の成長をさらに後押ししています。その結果、ヘルスケアプロバイダー、医療機器メーカー、研究開発者は、この需要の拡大に対応し、効果的な透析治療を提供するための革新的なソリューションや戦略を開発することに意欲を燃やしています。

民間透析クリニックとセンターの拡大

民間透析クリニックや透析センターの拡大が市場を強化しています。これらの民間施設には、市場拡大に影響を与えるいくつかの重要な利点があります。民間透析施設では、患者一人ひとりのニーズに合わせた専門的で個別化された治療が提供されることが多いです。このようなレベルのカスタマイズは、患者の満足度と治療成績を向上させ、より多くの顧客を惹きつけ、市場の需要を押し上げます。さらに、私立の透析センターは、患者の好みや日課に合わせて、より柔軟なスケジューリングオプションを提供する傾向があります。この利便性が、多忙なライフスタイルに合った治療を求める人々を惹きつけています。さらに、民間クリニックの設立は、市場内の健全な競争を促進します。この競争は、治療手法、技術導入、患者サービスの革新を促し、最終的には業界全体の医療の質の向上につながります。さらに、民間施設には最新の透析機器、技術、熟練した医療従事者が揃っていることが多く、効率的で効果的な治療が保証されています。このような高水準の医療は、患者や紹介元医師の信頼構築に役立ち、患者紹介と市場成長をさらに促進します。民間透析クリニックは、透析サービスを求める患者に別の選択肢を提供することで、公的ヘルスケアシステムの負担軽減に貢献しています。この側面は、公的資源が限られている地域では特に重要であり、民間透析センターはヘルスケアインフラの負担を軽減することができるからです。

持続的外来腹膜透析（CAPD）と自動腹膜透析（APD）の需要増加

持続的外来腹膜透析（CAPD）と自動腹膜透析（APD）の需要の高まりが、市場の成長を後押ししています。これらの先進的な腹膜透析技術には多くの利点があり、人気の高まりにつながっています。CAPDとAPDは、従来の施設内血液透析よりも柔軟で便利な治療オプションを患者に提供します。CAPDでは、患者さんは1日中手動で透析液の交換を行うことができるため、自由度が高く、治療を受けながら日常生活を続けることができます。APDは、夜間の透析液交換を機械で自動化することで、利便性をさらに高め、患者が睡眠中に治療を受けられるようにします。CAPDとAPDの需要は、安定した継続的な毒素除去が可能であるため、血液化学的状態がより安定し、全体的な健康状態が改善されることにあります。また、これらの技術は、透析センターへの頻繁な通院の必要性を最小限に抑え、患者の日常生活への支障を軽減します。さらに、CAPDとAPDは在宅医療に適しており、個別化ヘルスケアと遠隔モニタリングの増加傾向に合致しています。患者はこれらの手技を自宅で行うためのトレーニングを受けることができ、治療に対する権限委譲とコントロールの感覚を得ることができます。患者やヘルスケアプロバイダーがCAPDやAPDの利点をますます認識するようになるにつれて、これらの技術に対する需要が高まることが予想されます。その結果、腹膜透析技術のさらなる調査や技術革新が促進され、これらの方法を選択する患者のためのトレーニングプログラムやサポートサービスが拡大することで、市場の成長が促進されます。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の人工透析市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • 血液透析
    • 主要セグメント
      • 従来の血液透析
      • 短時間血液透析
      • 夜間血液透析
  • 腹膜透析
    • 主要セグメント
      • 持続携帯型腹膜透析（CAPD）
      • 自動腹膜透析（APD）

第7章 市場内訳：製品・サービス別

  • サービス
  • 装置
    • 主要セグメント
      • 透析装置
      • 水処理システム
      • その他
  • 消耗品
    • 主要セグメント
      • ダイアライザー
      • カテーテル
      • その他
  • 透析薬

第8章 市場内訳：エンドユーザー別

  • センター内透析
  • 在宅透析

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳：国別

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Asahi Kasei Corporation
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Becton Dickinson and Company
    • DaVita Inc.
    • Fresenius Medical Care AG & Co. KGaA
    • JMS Co. Ltd.
    • Medtronic plc
    • Nikkiso Co. Ltd.
    • NIPRO Corporation
    • Satellite Healthcare Inc.
    • Toray Industries Inc.
図表

List of Figures

  • Figure 1: Global: Dialysis Market: Major Drivers and Challenges
  • Figure 2: Global: Dialysis Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Dialysis Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Dialysis Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Dialysis Market: Breakup by Product and Services (in %), 2024
  • Figure 6: Global: Dialysis Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Dialysis Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Dialysis (Hemodialysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Dialysis (Hemodialysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Dialysis (Peritoneal Dialysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Dialysis (Peritoneal Dialysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Dialysis (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Dialysis (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Dialysis (Equipment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Dialysis (Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Dialysis (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Dialysis (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Dialysis (Dialysis Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Dialysis (Dialysis Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Dialysis (In-center Dialysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Dialysis (In-center Dialysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Dialysis (Home Dialysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Dialysis (Home Dialysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: United States: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: United States: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Canada: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Canada: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Asia-Pacific: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Asia-Pacific: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: China: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: China: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Japan: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Japan: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: India: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: India: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: South Korea: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: South Korea: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Australia: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Australia: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Indonesia: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Indonesia: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Others: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Others: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Europe: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Europe: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Germany: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Germany: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: France: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: France: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: United Kingdom: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: United Kingdom: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Italy: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Italy: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Spain: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Spain: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Russia: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Russia: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Latin America: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Latin America: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Brazil: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Brazil: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Mexico: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Mexico: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Middle East and Africa: Dialysis Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Middle East and Africa: Dialysis Market: Breakup by Country (in %), 2024
  • Figure 72: Middle East and Africa: Dialysis Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Global: Dialysis Industry: SWOT Analysis
  • Figure 74: Global: Dialysis Industry: Value Chain Analysis
  • Figure 75: Global: Dialysis Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Dialysis Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Dialysis Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Dialysis Market Forecast: Breakup by Product and Services (in Million USD), 2025-2033
  • Table 4: Global: Dialysis Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Dialysis Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Dialysis Market: Competitive Structure
  • Table 7: Global: Dialysis Market: Key Players
目次
Product Code: SR112025A5940

The global dialysis market size was valued at USD 120.85 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 180.42 Billion by 2033, exhibiting a CAGR of 4.09% during 2025-2033. North America currently dominates the market in 2024, accounting to 41.0% of the market share. The major drivers of the market include the increasing prevalence of chronic kidney disease and end-stage renal disease, rising diabetes and hypertension cases, technological advancements in dialysis equipment, growing healthcare spending, expanding home dialysis solutions, favorable government policies, reimbursement initiatives, and an aging global population.

Dialysis is a crucial renal replacement therapy for individuals whose kidneys cannot function naturally. This medical procedure plays a vital role in eliminating toxins, excess water, salts, and solutes from the patient's bloodstream, effectively restoring a healthier balance. The primary objective of dialysis is to purify the blood and restore proper electrolyte levels within the body. This therapy comes in two main forms: hemodialysis and peritoneal dialysis. Hemodialysis involves the external purification of blood, a process that occurs outside the body. This technique effectively cleanses the blood of impurities, helping patients regain stability. On the other hand, peritoneal dialysis relies on the peritoneum, a lining within the abdomen, to purify the blood. By utilizing the peritoneum as a dialysis medium, this method offers an internal approach to blood cleansing. Both hemodialysis and peritoneal dialysis are instrumental in treating various kidney-related conditions. These treatments are commonly employed for addressing acute renal injuries, managing chronic kidney diseases, supporting kidney transplant procedures, or serving as a permanent solution when transplantation is not a viable option. The significance of dialysis cannot be overstated, as it significantly enhances the quality of life for individuals grappling with kidney dysfunctions. Through careful implementation and ongoing advancements in medical technology, dialysis continues to serve as a lifeline for patients needing renal support.

The global market is majorly driven by the increasing prevalence of chronic kidney diseases. In line with this, the rising aging population prone to kidney-related issues is significantly contributing to the market. Furthermore, the growing awareness about renal health and available treatment options is positively influencing the market. Apart from this, the rapid technological advancements leading to more efficient dialysis procedures are offering numerous opportunities for the market. Moreover, the heavy investments in research and development of innovative dialysis techniques are catalyzing the market. Besides, the higher incidence of diabetes, a major contributor to kidney diseases, is propelling the demand for dialysis. Additionally, the expansion of healthcare infrastructure in developing regions is providing a boost to the market. The escalating demand for home-based dialysis solutions is strengthening the market.

Dialysis Market Trends/Drivers:

Increasing lifestyle changes lead to kidney complications

The escalating trend of lifestyle changes is stimulating the market. Modern lifestyles characterized by poor dietary habits, sedentary routines, and high-stress levels contribute to a rise in kidney complications. Unhealthy diets rich in processed foods, high salt content, and inadequate hydration can lead to chronic conditions such as hypertension and diabetes, which are major causes of kidney diseases. The correlation between lifestyle factors and kidney complications has prompted an upswing in the prevalence of chronic kidney diseases. This rise in kidney-related issues has subsequently increased the demand for dialysis treatments, as affected individuals require renal replacement therapy to maintain their quality of life. The expanding patient pool necessitates the expansion of dialysis services, further driving the growth of the dialysis market. Consequently, healthcare providers, medical device manufacturers, and researchers are motivated to develop innovative solutions and strategies to address this growing demand and offer effective dialysis interventions.

Expansion of private dialysis clinics and centers

The expansion of private dialysis clinics and centers is bolstering the market. These private facilities offer several key advantages that contribute to their impact on market expansion. Private clinics often provide specialized and personalized care tailored to the unique needs of individual patients. This level of customization enhances patient satisfaction and outcomes, attracting a larger clientele and boosting market demand. Furthermore, private dialysis centers tend to offer more flexible scheduling options, accommodating patients' preferences and routines. This convenience factor attracts individuals seeking treatments that align with their busy lifestyles. Moreover, the establishment of private clinics fosters healthy competition within the market. This competition encourages innovation in treatment methodologies, technology adoption, and patient services, ultimately leading to improved quality of care across the industry. Additionally, private facilities are often well-equipped with the latest dialysis machines, technologies, and skilled medical personnel, ensuring efficient and effective treatments. This high standard of care helps build trust among patients and referring physicians, further driving patient referrals and market growth. Private dialysis clinics contribute to reducing the burden on public healthcare systems by providing alternative options for patients seeking dialysis services. This aspect is particularly crucial in regions with limited public resources, as private centers can alleviate strain on the healthcare infrastructure.

Rising demand for continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)

The escalating demand for Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD) is fueling the market growth. These advanced peritoneal dialysis techniques offer numerous advantages that contribute to their increasing popularity. CAPD and APD provide patients with more flexible and convenient treatment options than traditional in-center hemodialysis. CAPD allows patients to perform manual exchanges of dialysate fluid throughout the day, offering greater freedom and the ability to continue daily activities while undergoing treatment. APD takes convenience a step further by utilizing a machine to automate dialysate exchanges at night, allowing patients to receive treatment while they sleep. The demand for CAPD and APD is driven by their ability to provide steady and continuous toxin removal, leading to more stable blood chemistry and improved overall health. These techniques also minimize the need for frequent visits to a dialysis center, reducing the disruption to patients' daily lives. Furthermore, CAPD and APD are well-suited for home-based care, aligning with the growing trend towards personalized healthcare and remote monitoring. Patients can receive training to perform these procedures at home, giving them a sense of empowerment and control over their treatment. As patients and healthcare providers increasingly recognize the benefits of CAPD and APD, the demand for these techniques is expected to rise. This, in turn, drives market growth by encouraging further research and innovation in peritoneal dialysis technology, as well as the expansion of training programs and support services for patients opting for these methods.

Dialysis Industry Segmentation:

Breakup by Type:

  • Hemodialysis
  • Conventional Hemodialysis
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis
  • Peritoneal Dialysis
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

Hemodialysis dominates the market

Hemodialysis, a prominent renal replacement therapy, exerts substantial influence due to its widespread adoption and several associated factors. Its efficacy in rapidly removing toxins, excess fluids, and waste products from the bloodstream addresses critical medical needs in patients with kidney dysfunction. As a result, its demand is driven by the growing prevalence of chronic kidney diseases, kidney failures, and related conditions. The continuous advancement of hemodialysis technology has improved treatment outcomes and enhanced patient experiences.

Innovations such as high-efficiency dialyzers, vascular access techniques, and online monitoring systems have made hemodialysis more effective, comfortable, and accessible. Moreover, establishing specialized hemodialysis centers and integrating telehealth solutions has widened the reach of this treatment, making it accessible to more patients, including those in remote areas. These factors combined contribute to the segment's pivotal role in driving overall market growth as the demand for efficient renal replacement therapies rises.

Breakup by Product and Services:

  • Services
  • Equipment
  • Dialysis Machines
  • Water Treatment Systems
  • Others
  • Consumables
  • Dialyzers
  • Catheters
  • Others
  • Dialysis Drugs

Services dominates the market

The services segment is vital in driving market growth within the dialysis industry. This segment encompasses a range of essential offerings that directly impact patient care, treatment accessibility, and overall industry expansion. Medical service providers, including healthcare professionals and specialized dialysis clinics, contribute significantly to the growth of this segment. These services encompass various aspects of patient care, from initial diagnosis and treatment planning to ongoing monitoring and support. The availability of high-quality medical services is crucial in attracting patients to seek timely interventions for kidney-related issues.

Furthermore, the services segment includes patient education and awareness initiatives. These programs empower patients with knowledge about kidney health, available treatment options, and self-care practices. By raising awareness and promoting early intervention, these educational efforts contribute to higher demand for dialysis services. The expansion of telehealth services is also a driving factor. Remote monitoring and consultation services enable patients to access medical guidance without frequent in-person visits, making dialysis care more convenient and efficient.

Breakup by End User:

  • In-center Dialysis
  • Home Dialysis

In-center dialysis dominates the market

The in-center dialysis segment is a key driver of market growth within the dialysis industry. This segment caters to a substantial portion of the patient population, contributing significantly to the demand for dialysis services. In-center dialysis refers to treatments conducted within specialized dialysis centers or clinics under the supervision of trained medical professionals. This setting offers various advantages, including access to advanced medical equipment, close monitoring by healthcare staff, and the opportunity for patients to interact with peers facing similar health challenges.

The convenience and comprehensive care provided by in-center dialysis centers attract patients who require regular and closely supervised treatments. This includes individuals with advanced kidney diseases, complex medical histories, or those who benefit from personalized care plans. Moreover, in-center dialysis centers often house cutting-edge technology and skilled healthcare teams, ensuring high-quality treatment delivery. Patients appreciate the structured environment, professional support, and regular check-ins that in-center dialysis provides.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

With its well-established healthcare infrastructure, North America is at the forefront of adopting and implementing innovative dialysis technologies and treatment methodologies. This region's focus on research and development fosters continuous advancements in dialysis machines, equipment, and treatment protocols, enhancing the overall quality of patient care. The increasing prevalence of chronic kidney diseases, often associated with lifestyle factors such as obesity and diabetes, drives the demand for dialysis services in North America. A significant aging population also contributes to the rising need for renal replacement therapies.

Government initiatives, reimbursement policies, and awareness campaigns further promote early diagnosis and intervention for kidney-related issues, boosting the utilization of dialysis treatments. Additionally, the concentration of leading dialysis companies and medical research institutions in North America fuels the development and dissemination of state-of-the-art dialysis solutions.

Competitive Landscape:

Top companies are playing a crucial role in fostering the growth of the dialysis market through strategic initiatives and innovations. Armed with their extensive resources and expertise, these companies are driving market expansion in several ways. They invest heavily in research and development, leading to the creation of advanced dialysis technologies and treatment methods. This continuous innovation improves dialysis's efficacy, efficiency, and patient experience, enticing more individuals to opt for these treatments. Moreover, these companies collaborate with healthcare providers and institutions, ensuring widespread access to their products and services. Such partnerships facilitate the integration of cutting-edge dialysis solutions into existing healthcare ecosystems, thus expanding the market reach. Additionally, top companies often engage in awareness campaigns to educate the medical community and the general public about kidney health and available treatment options. This educational effort drives early diagnosis and intervention, increasing the demand for dialysis services. Besides, their global presence and distribution networks enable them to bring advanced dialysis solutions to regions with limited access to healthcare infrastructure. This expansion into underserved areas contributes to market growth by catering to a wider patient demographic.

The report has provided a comprehensive analysis of the competitive landscape in the dialysis market. Detailed profiles of all major companies have also been provided.

  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • DaVita Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • JMS Co. Ltd.
  • Medtronic plc
  • Nikkiso Co. Ltd.
  • NIPRO Corporation
  • Satellite Healthcare Inc.
  • Toray Industries Inc.

Key Questions Answered in This Report

  • 1.How big is the dialysis market?
  • 2.What is the future outlook of the dialysis market?
  • 3.What are the key factors driving the dialysis market?
  • 4.Which region accounts for the largest dialysis market share?
  • 5.Which are the leading companies in the global dialysis market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Dialysis Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Hemodialysis
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Conventional Hemodialysis
      • 6.1.2.2 Short Daily Hemodialysis
      • 6.1.2.3 Nocturnal Hemodialysis
    • 6.1.3 Market Forecast
  • 6.2 Peritoneal Dialysis
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Continuous Ambulatory Peritoneal Dialysis (CAPD)
      • 6.2.2.2 Automated Peritoneal Dialysis (APD)
    • 6.2.3 Market Forecast

7 Market Breakup by Product and Services

  • 7.1 Services
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Equipment
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Dialysis Machines
      • 7.2.2.2 Water Treatment Systems
      • 7.2.2.3 Others
    • 7.2.3 Market Forecast
  • 7.3 Consumables
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Dialyzers
      • 7.3.2.2 Catheters
      • 7.3.2.3 Others
    • 7.3.3 Market Forecast
  • 7.4 Dialysis Drugs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 In-center Dialysis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Dialysis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Asahi Kasei Corporation
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 B. Braun Melsungen AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 DaVita Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Fresenius Medical Care AG & Co. KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 JMS Co. Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Medtronic plc
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Nikkiso Co. Ltd.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 NIPRO Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Satellite Healthcare Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Toray Industries Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis